PRME Latest Press Releases

-- July 23, 2026 --

Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease Globe Newswire 4:05 PM

-- July 8, 2026 --

Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics Globe Newswire 8:00 AM

-- June 22, 2026 --

Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) Globe Newswire 8:00 AM

-- June 18, 2026 --

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease Globe Newswire 8:00 AM

-- June 3, 2026 --

Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference Globe Newswire 8:00 AM

-- May 28, 2026 --

Prime Medicine to Present at Jefferies Global Healthcare Conference Globe Newswire 8:00 AM

-- May 7, 2026 --

Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 8:00 AM

-- April 16, 2026 --

Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer Globe Newswire 8:00 AM

-- March 3, 2026 --

Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software